State-of-the-art colloidal particles and unique interfaces-based SARS-CoV-2 detection methods and COVID-19 diagnosis

Ebru Saatçi; Satheesh Natarajan

doi:10.1016/j.cocis.2021.101469

State-of-the-art colloidal particles and unique interfaces-based SARS-CoV-2 detection methods and COVID-19 diagnosis

Curr Opin Colloid Interface Sci. 2021 Oct:55:101469. doi: 10.1016/j.cocis.2021.101469. Epub 2021 May 29.

Authors

Ebru Saatçi¹, Satheesh Natarajan²

Affiliations

¹ Erciyes University, Faculty of Science, Biology Department, 38039, Kayseri, Turkey.
² Healthcare Technology Innovation Centre, Indian Institute of Technology, Madras, 600113, Tamilnadu, India.

Abstract

In March 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-based infections were declared 'COVID-19 pandemic' by the World Health Organization. Pandemic raised the necessity to design and develop genuine and sensitive tests for precise specific SARS-CoV-2 infections detection. Nanotechnological methods offer new ways to fight COVID-19. Nanomaterials are ideal for unique sensor platforms because of their chemically versatile properties and they are easy to manufacture. In this context, selected examples for integrating nanomaterials and distinct biosensor platforms are given to detect SARS-CoV-2 biological materials and COVID-19 biomarkers, giving researchers and scientists more goals and a better forecast to design more relevant and novel sensor arrays for COVID-19 diagnosis.

Keywords: COVID-19 biomarkers; Colloidal nanoparticles; Interfaces; SARS-CoV-2.

Publication types

Review